Article 2022 · 0 atıf

mFOLFOX-based Chemotherapy Can Augment Survival in Advanced Gastric Cancer Patient with Disseminated Intravascular Coagulation

Aldemir, M. N., Turkeli, M., Simsek, M., Cayir, K., Yildirim, N., Bilici, N. M., Ayan, A. K., Tekin, S. B.

Özet

Although gastric cancer is a frequent cancer type, disseminated intravascular coagulation is a very rare but serious complication of this disease. We report a 65-year-old man who complained of weight loss, nausea and vomiting, fatigue and dyspnoea for three days. He was diagnosed as having advanced gastric cancer complicated with disseminated intravascular coagulation, which was successfully treated with mFOLFOX chemotherapy regimen. After one cycle of mFOLFOX therapy, thrombocytopenia was improved and serum lactate dehydrogenase levels decreased. Remarkable remission was seen. After 12 cycles of chemotherapy, remarkable remission was seen in the primary tumour and multiple metastatic bone lesions.

Anahtar Kelimeler

Advanced gastric cancer disseminated intravascular coagulation mFOLFOX-based chemotherapy 5-FLUOROURACIL

WoS Kategorileri

Medicine, General & Internal

Sürdürülebilir Kalkınma Amaçları

Sağlık ve Kaliteli Yaşam

Künye

Dergi: WEST INDIAN MEDICAL JOURNAL
Yıl: 2022
Cilt: 69
Sayı: 7
Sayfa: 520-522
ISSN: 0043-3144
eISSN: 2309-5830
DOI: 10.7727/wimj.2015.271
WoS UID: WOS:000794032100011

Yayını aç (DOI)